View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Global Supply by Local Distribution

To provide the best possible customer service, Novo Nordisk Pharmaceuticals now offers distribution from two separate warehouse locations that serve a global client base. One is located in Plainfield, Indiana, US, and the other facility is located near Copenhagen, Denmark.

We know that one of the most important parameters is the security of supply; the US distribution centre enables Novo Nordisk Pharmaceuticals to provide you with the desired products within seven days shipping or less virtually anywhere in the United States, utilizing MD Logistics (MDL) as our third-party logistic provider.

This new distribution centre allows us to improve the delivery performance of our products in case of unexpected weather conditions in Europe, e.g. ash clouds. It also prevents any delays from the US import formalities (US Customs, FDA, USDA).

Both of Novo Nordisk Pharmaceuticals distribution centers maintain a strict compliance with all applicable laws, regulations and ordinances. We store and handle our Insulin Human AF in conformance with manufacturer requirements, including, without limitation, any applicable climate control requirements.

Technologically advanced systems are applied to regulate the temperature of the storage equipment in both distribution centers. The product storage is protected by around-the-clock security, and a complete facility power backup in the event of a power loss or interruption.

With this new local distribution we will be able to guarantee you:

  • A short delivery lead-time
  • A high delivery precision
  • A secure global supply chain

Should you have any questions or require more information regarding our new US local distribution, please do not hesitate to contact us.

For more than 30 years, the National Research Council of Canada has been helping clients develop, optimise, scale-up and transfer bioprocesses to produce biologics and...
The Chinese hamster ovary (CHO) cell line is widely used for the production of recombinant proteins due to its high growth capacity and productivity, as...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology